Does Adding Pembro Improve PFS in High-Risk Cervical Cancer?
Pembrolizumab improved progression-free survival when added to standard chemoradiotherapy in newly diagnosed, locally advanced cervical cancer, new data show.
Stay updated with breaking news from Lymph Nodes. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pembrolizumab improved progression-free survival when added to standard chemoradiotherapy in newly diagnosed, locally advanced cervical cancer, new data show.
The new approval expands the melanoma indication for nivolumab to earlier-stage disease.
Patients with early breast cancer and negative ultrasound axillary lymph node staging had similar locoregional relapse and distant DFS at 5 years whether or not they received SLN biopsy.
A Ludwig Cancer Research study has shown that combining adoptive T cell therapy (ACT) with an innovative, personalized cancer vaccine under development at the Lausanne Branch of the Ludwig Institute for Cancer Research can benefit patients with late-stage, drug-resistant ovarian cancer.
A recent review in the journal Immunity delves into the crucial role of dendritic cells (DCs) in shaping T-cell responses in cancer, highlighting their importance in both priming anti-tumor immunity and in ongoing immune interactions within tumors. The findings underscore the potential of DCs as key targets for next-generation cancer immunotherapies.